•• Scolding N: Central nervous system vasculitis. Semin Immunopathol 2009, 31:527–536. This is an excellent review of the current pathology, clinical features, and diagnosis of CNS vasculitis.
Jennette JC, Falk RJ, Andrassy K, et al.: The proposal of an international consensus conference. Arthritis Rheum 1994, 37:187–192.
Hunder GG, Arend WP, Bloch DA, et al.: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33:1065–1067.
•• Kuker W: Cerebral vasculitis: imaging signs revisited. Neuroradiology 2007, 49:471–479. This is an excellent review of the imaging in cerebral vasculitis. A modified approach to the Chapel Hill classification is proposed.
Kaufmann TJ, Kallmes DF: Diagnostic cerebral angiography: archaic and complication-prone or here to stay for another 80 years? AJR Am J Roentgenol 2008, 1:1435–1437.
Nishikawa M, Sakamoto H, Katsuyama J, et al.: Multiple appearing and vanishing aneurysms: primary angiitis of the central nervous system. J Neurosurg 1998, 88:133–137.
Willinsky RA, Taylor SM, TerBrugge K, et al.: Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology 2003, 227:522–528.
Yahyavi-Firouz-Abadi N, Wynn BL, Rybicki FJ, et al.: Steroid-responsive large vessel vasculitis: application of whole-brain 320-detector row dynamic volume CT angiography and perfusion. AJNR Am J Neuroradiol 2009, 30:1409–1411.
Blockmans D, Bley T, Schmidt W: Imaging for large-vessel vasculitis. Curr Opin Rheumatol 2009, 21:19–28.
Kraemer M, Berlit P: Systemic, secondary and infectious causes for cerebral vasculitis: clinical experience with 16 new European cases. Rheumatol Int 2009 Oct 13 (Epub ahead of print).
Harris KG, Tran DD, Sickels WJ, et al.: Diagnosing intracranial vasculitis: the roles of MR and angiography. AJNR Am J Neuroradiol 1994, 15:317–330.
Calabrese LH, Duna GF, Lie JT: Vasculitis in the central nervous system. Arthritis Rheum 1997, 40:1189–1201.
Aviv RI, Benseler SM, Silverman ED, et al.: MR imaging and angiography of primary CNS vasculitis of childhood. AJNR Am J Neuroradiol 2006, 27:192–199.
Wasserman BA, Stone JH, Hellmann DB, Pomper MG: Reliability of normal findings on MR imaging for excluding the diagnosis of vasculitis of the central nervous system. AJR Am J Roentgenol 2001, 177:455–459.
Cloft HJ, Phillips CD, Dix JE, et al.: Correlation of angiography and MR imaging in cerebral vasculitis. Acta Radiol 1999, 40:83–87.
Deibler AR, Pollock JM, Kraft RA, et al.: Arterial spin-labeling in routine clinical practice, part 2: hypoperfusion patterns. AJNR Am J Neuroradiol 2008, 29:1235–1241.
White ML, Hadley WL, Zhang Y, Dogar MA: Analysis of central nervous system vasculitis with diffusion-weighted imaging and apparent diffusion coefficient mapping of the normal-appearing brain. AJNR Am J Neuroradiol 2007, 28:933–937.
Scolding N: Can diffusion weighted imaging improve the diagnosis of CNS vasculitis? Nat Clin Pract Neurol 2007, 3:608–609.
Sundgren PC, Jennings J, Attwood JT, et al.: MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus. Neuroradiology 2005, 47:576–585.
Appenzeller S, Li LM, Costallat LT, Cendes F: Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus. Lupus 2007, 16:963–971.
Minagar A, Fowler M, Harris MK, Jaffe SL: Neurologic presentations of systemic vasculitides. Neurol Clin 2010, 28:171–184.
Bongartz TM: Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol 2006, 18:7–10.
Schmidt WA, Kraft HE, Vorpahl K, et al.: Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997, 337:1336–1342.
Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP: Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med 2005, 142:359–369.
Pipitone N, Salvarani C: Role of imaging in vasculitis and connective tissue diseases. Best Pract Res Clin Rheumatol 2008, 22:1075–1091.
Bley TA, Uhl M, Carew J, et al.: Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol 2007, 28:1722–1727.
Geiger J, Ness T, Uhl M, et al.: Involvement of the ophthalmic artery in giant cell arteritis visualized by 3 T MRI. Rheumatology 2009, 48:537–541.
Bley TA, Geiger J, Jacobsen S, et al.: High-resolution MRI for assessment of middle meningeal artery involvement in giant cell arteritis. Ann Rheum Dis 2009, 68:1369–1370.
Andrews J, Mason JC: Takayasu’s arteritis—recent advances in imaging offer promise. Rheumatology 2007, 46:6–15.
Desai MY, Stone JH, Foo TKF, et al.: Delayed contrast-enhanced MRI of the aortic wall in Takayasu’s arteritis: initial experience. AJR Am J Roentgenol 2005, 184:1427–1431.
Webb M, Chambers A, Al-Nahhas A, et al.: The role of FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 2004, 31:627–634.
Schmidley J, ed: Central Nervous System Angiitis. Boston, MA: Butterworth-Heinemann; 2000.
Birnbaum J, Hellmann DB: Primary angiitis of the central nervous system. Arch Neurol 2009, 66:704–709.
Molloy ES, Singhal AB, Calabrese LH: Tumour-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system. Ann Rheum Dis 2008, 67:1732–1735.
Tong KA, Ashwal S, Obenaus A, et al.: Susceptibility-weighted MR imaging: a review of clinical applications in children. AJNR Am J Neuroradiol 2008, 29:9–17.
Lee Y, Kim J-H, Kim E, et al.: Tumor-mimicking primary angiitis of the central nervous system: initial and follow-up MR features. Neuroradiology 2009, 51:651–659.
Von Morze C, Purcell D, Banerjee S, et al.: High resolution intracranial MRA at 7 T using autocalibrating parallel imaging: initial experience in vascular disease patients. Magn Reson Imaging 2008, 26:1329–1333.
Woolfenden AR, Hukin J, Poskitt KJ, Connolly MB: Encephalopathy complicating Henoch-Schonlein purpura: reversible MRI changes. Pediatr Neurol 1998, 19:74–77.
Berlit P: Diagnosis and treatment of cerebral vasculitis. Ther Adv Neurol Disord 2009, 28:1–14.
Jacobi C, Wildemann B, Wengenroth M: Imaging of cerebral vasculitis. In Inflammatory Disease of the Brain, edn 1. Edited by Hahnel S. Berlin: Springer-Verlag; 2009:26–50
Matsushima M, Yaguchi H, Niino M, et al.: MRI and pathological findings of rheumatoid meningitis. J Clin Neurosci 2010, 17:129–132.
Jones SE, Belsley NA, McLoud TC, Mullins ME: Rheumatoid meningitis: radiological and pathological correlation. AJR Am J Roentgenol 2006, 186:1181–1183.
Abe K: MRI of central nervous system vasculitis. Curr Med Imaging Rev 2006, 2:425–434.
Citron BP, Halpern M, McCarron M, et al.: Necrotizing angiitis associated with drug abuse. N Engl J Med 1970, 283:1003–1011.
Geibprasert S, Gallucci M, Krings T: Addictive illegal drugs: structural neuroimaging. AJNR Am J Neuroradiol 2009 Oct 29 (Epub ahead of print).
Wynne PJ, Younger DS, Khandji A, Silver AJ: Radiographic features of central nervous system vasculitis. Neurol Clin 1997, 15:779–804.
Hajj-Ali RA, Calabrese LH: Central nervous system vasculitis. Curr Opin Rheumatol 2009, 21:10–18.
Ducros A, Boukobza M, Porcher R, et al.: The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007, 130:3091–3101.
Hankey G: Isolated angiitis/angiopathy of the CNS. Prospective diagnostic and therapeutic experience. Cerebrovasc Dis 1991, 1:2–15.